Campath 1H

Known as: Campath-1H, Monoclonal Antibody Campath-1H 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Phase II clinical trials revealed that the lymphocyte-depleting humanized monoclonal antibody alemtuzumab (Campath-1H) is highly… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Campath-1H, an anti-CD52 monoclonal antibody, was used as induction therapy (40 mg i.v. total dose) in 29 primary human renal… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
This study investigated the efficacy, safety, and clinical benefit of alemtuzumab (Campath-1H) for patients with relapsed or… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Nonmyeloablative conditioning is increasingly used for transplantation in a wide range of diseases, but little is known about its… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
We describe 21 patients with severe and life-threatening autoimmune cytopenias resistant to standard immunosuppression who were… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
T-cell prolymphocytic leukemia (T-PLL) is a chemotherapy-resistant malignancy with a median survival of 7.5 months. Preliminary… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A novel nonmyeloablative conditioning regimen was investigated in 44 patients with hematologic malignancies. The median patient… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
PURPOSE CAMPATH-1H is a human immunoglobulin G1 (IgG1) anti-CD52 monoclonal antibody (MAb) that binds to nearly all B- and T-cell… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
The humanized antibody CAMPATH-1H has been shown in pilot studies to be beneficial in the treatment of lymphoid malignancy and… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
A genetically reshaped human IgG1 monoclonal antibody (CAMPATH-1H) was used to treat two patients with non-Hodgkin lymphoma… (More)
Is this relevant?